Proteome‐Wide Genetic Study Identified ENTPD5 as a Candidate Target for Obesity‐Related MASLD

ABSTRACT Objective This study aimed to discover causal plasma proteins for metabolic dysfunction‐associated steatotic liver disease (MASLD) using trans‐ancestry genetic data. Methods We performed proteome‐wide Mendelian randomization (MR) for 1256 proteins and MASLD using genome‐wide association data from East Asian ( n = 85,124) and European ( n = 500,348) populations. Colocalization was conducted to validate putative causal proteins for MASLD, followed by two‐step MR assessing adiposity mediation. Longitudinal cross‐lagged analysis in a bariatric surgery cohort ( n = 53) was used to assess temporal associations. Results ENTPD5 and APOE showed consistent causal effects in both East Asians and Europeans, both supported by colocalization. Both proteins influenced MASLD risk through adiposity, with BMI mediating 15.7% of the ENTPD5 effect. Longitudinal analysis in the bariatric surgery cohort supported the temporal pathway “ENTPD5→BMI reduction→MASLD remission (assessed by the fatty liver index),” with 29.2% mediation by BMI. Phenome‐wide MR revealed a broad pleiotropic profile of ENTPD5, warranting further evaluation of target safety and repurposing potential. Conclusions These findings suggest that ENTPD5 and APOE are potential causal biomarkers for MASLD and may contribute to its pathogenesis. ENTPD5 represents a candidate target for obesity‐related diseases, although its pleiotropic profile warrants further investigation.

Authors

Institutions

Publication Details

Journal
Obesity
Published
2026-11-15
DOI
https://doi.org/10.1002/oby.70323
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Proteome‐Wide Genetic Study Identified ENTPD5 as a Candidate Target for Obesity‐Related MASLD

Daniel Avery, Ling Yang, Dianjianyi Sun, Canqing Yu et al.
Obesity
Liver Disease Diagnosis and Treatment
article

Proteome‐Wide Genetic Study Identified ENTPD5 as a Candidate Target for Obesity‐Related MASLD

Daniel Avery, Ling Yang, Dianjianyi Sun, Canqing Yu, Pang Yao, Iona Y. Millwood, Robin G. Walters, Zhiyu Wu, Xinyao Wang, Huaidong Du, Yuanjie Pang, Liming Li, Zhongtao Zhang, Yang Liu, Huajing Yu, Junshi Chen, Jun Lv, Pei Pei, Ting Wu, Yating Huang, Mengyi Li, Yiping Chen, Peng Zhang, the China Kadoorie Biobank Collaborative Group, Zhengming Chen, Yuan Cao
article en

Abstract

ABSTRACT Objective This study aimed to discover causal plasma proteins for metabolic dysfunction‐associated steatotic liver disease (MASLD) using trans‐ancestry genetic data. Methods We performed proteome‐wide Mendelian randomization (MR) for 1256 proteins and MASLD using genome‐wide association data from East Asian ( n = 85,124) and European ( n = 500,348) populations. Colocalization was conducted to validate putative causal proteins for MASLD, followed by two‐step MR assessing adiposity mediation. Longitudinal cross‐lagged analysis in a bariatric surgery cohort ( n = 53) was used to assess temporal associations. Results ENTPD5 and APOE showed consistent causal effects in both East Asians and Europeans, both supported by colocalization. Both proteins influenced MASLD risk through adiposity, with BMI mediating 15.7% of the ENTPD5 effect. Longitudinal analysis in the bariatric surgery cohort supported the temporal pathway “ENTPD5→BMI reduction→MASLD remission (assessed by the fatty liver index),” with 29.2% mediation by BMI. Phenome‐wide MR revealed a broad pleiotropic profile of ENTPD5, warranting further evaluation of target safety and repurposing potential. Conclusions These findings suggest that ENTPD5 and APOE are potential causal biomarkers for MASLD and may contribute to its pathogenesis. ENTPD5 represents a candidate target for obesity‐related diseases, although its pleiotropic profile warrants further investigation.

Obesity
Capital Medical University (CN), Peking University (CN), University of Oxford (GB), National Clinical Research Center for Digestive Diseases (CN), China National Center for Food Safety Risk Assessment (CN), Beijing Friendship Hospital (CN)
Liver Disease Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon